“Our collaboration with DTA provides a unique opportunity to advance global digital therapeutics development and adoption. As we build robust solution accelerators for the development and deployment of DTx solutions, the alliance provides us with a strong platform to engage in deeper collaboration and incorporate the latest innovations in design and technology for achieving better patient engagement and outcomes.,” said Suhas Tamras, VP and Head of Healthcare & Life Sciences Business at Tata Elxsi.